234. Peroxisomal disease (except Adrenoleukodystrophy) Disease details / Clinical trials / Drug dev / DR info

---

Clinical trials : 39 /  Drugs : 35 - (DrugBank : 12) / Drug target genes : 13 - Drug target pathways : 45

Previous names	-
Other names	Peroxisomal disease;Peroxisomal disorder;Peroxisome biogenesis disorder;
Disease group	Metabolic diseases
Related info (in Japanese)	-
Designated intractable diseases (in Japanese)	Overview, Diagnostic criteria, etc. (docx), Clinical research form (pdf) (1), (2), (3), (4), (5), (6)
Specific pediatric chronic diseases, Japan (in Japanese)	8-2-35. Primary hyperoxaluria
	8-7-106. Other peroxisomal diseases
Subtypes	No.	Name	Specific pediatric chronic diseases, Japan (in Japanese)
	234-1.	Peroxisome biogenesis disorder;PEX gene disorder;Zellweger syndrome;Neonatal adrenoleukodystrophy;Infantile Refsum disease;Rhizomelic chondrodysplasia punctata type 1;RCDP type 1;RCDP1;	8-7-103. Peroxisome Biogenesis Disorders
	234-2.	Peroxisomal beta-oxidation enzyme deficiency;Acyl-CoA oxidase deficiency;AOX deficiency;D-Bifunctional protein deficiency;DBP deficiency;Sterol carrier protein X deficiency;SCPx deficiency;2-methylacyl-CoA racemase deficiency;Alpha-methylacyl-CoA racemase deficiency;AMACR deficiency;
	234-3.	Plasmalogen biosynthesis enzyme deficiency;Rhizomelic chondrodysplasia punctata type 2;RCDP type 2;RCDP2;Rhizomelic chondrodysplasia punctata type 3;RCDP type 3;RCDP3;
	234-4.	Refsum disease;	8-7-105. Refsum disease
	234-5.	Primary hyperoxaluria type 1;PH1;	8-2-35. Primary hyperoxaluria
	234-6.	Acatalasemia;Acatalasia;Takahara disease;
	234-7.	Contiguous ABCD1/DXS1357E deletion syndrome;CADDS;